A $500 annual blood testing membership promises to help consumers take their health into their own hands. Can it deliver?

Of the 258 participants, 195 were cognitively asymptomatic, 34 had mild cognitive impairment, 23 had dementia, and six had an ...

A blood test for insulin resistance (a hallmark of diabetes) may offer clues about the speed of memory loss for people with early Alzheimer’s disease.

A 7-year-old girl with autism was hit by a car while retrieving a ball in DeKalb County; the driver fled the scene after initially stopping.

The Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test is designed for the early detection of amyloid plaques associated with Alzheimer’s disease in adults aged 55 years and older who are ...

No. The F.D.A., and Alzheimer’s experts, emphasized that the blood test should be given only to people who are already experiencing cognitive decline and are ages 55 and older.

In clinical trials, the Lumipulse blood test was highly accurate at detecting brain plaques tied to Alzheimer’s disease, which paved the way for FDA approval. Compared to brain scans and spinal ...

The FDA has cleared the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test, the first blood test for early Alzheimer's detection in adults aged 55 and older showing symptoms. It analyzes ...

WASHINGTON — U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer’s and identify patients who may benefit from drugs that can modestly slow the memory ...

May 16 (UPI) -- The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in patients beginning to show cognitive decline.

The test, called Lumipulse, measures two proteins found in the blood’s plasma to determine whether a patient has amyloid plaques in the brain. Up until now, physicians have mostly used costly ...

The test, called the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, is for adults 55 and older who are showing signs and symptoms of Alzheimer’s disease, the FDA announced Friday.